Navigation Links
Study Finds Starion Instruments' Tissue Welding Technology Safe and Effective in Parotidectomy Procedures
Date:3/4/2008

Technology minimizes risk of postoperative facial paresis

SUNNYVALE, Calif., March 4 /PRNewswire/ -- Starion Instruments, a leading surgical device company, today announced that a study published in the January 2008 issue of The American Surgeon found Starion's patented Tissue Welding technology minimized intraoperative blood loss, postoperative complications and may reduce the development of facial paresis in parotidectomy procedures.

The study, Tissue Welding Forceps Usage in Superficial Parotidectomy: A Clinical Assessment, was conducted by Randall Michel, M.D., FACS, Kang Tsau, M.D., and Bernard Weinstock, M.D. from the Departments of Surgery and Anesthesiology, Lompoc Valley Medical Center, Lompoc, CA. Michel and his colleagues performed a retrospective review of 25 patients who underwent superficial parotidectomy using Starion's ENTceps to assess safety and effectiveness of the technology. Of particular interest was the incidence of facial nerve palsy since this is one of the most severe complications associated with parotid procedures.

The review included 10 men and 15 women, aged 25 to 88 years, diagnosed with benign or malignant disease. The researchers reviewed records for operative times, estimated blood loss and postoperative complications of bleeding, facial nerve paresis, salivary fistula, and gustatory sweating, and compared these results with previous reports using other parotid dissection techniques.

With Starion's ENTceps, Michel and his team found the average operative time was 155.6 minutes, average blood loss was 71.6 cc, there were no instances of delayed bleeding, clinical Frey's syndrome, clinical gustatory sweating or wound infections, and only one patient had transient forehead weakness. These results compared favorably to alternate methods for superficial parotidectomy.

"Our experience to date using ENTceps has been quite positive," said Michel. "The main advantages are that this instrument can be used close to the facial nerve and that no current passes through the patient, enabling continuous monitoring of the facial nerve. The ability to continuously monitor nerves during the procedure helps minimize the risk for inadvertent injury and subsequent facial nerve palsy."

About Starion Instruments

Starion develops advanced surgical devices that enhance performance, minimize risk and improve patient outcomes. Starion's instruments employ a patented Tissue Welding technology that seals and divides soft tissue with only focused heat and pressure. Known for their effectiveness, reliability and versatility, Starion's products are used worldwide for open and endoscopic cardiac, gynecology, general surgery, otolaryngology and urology procedures. Please visit http://www.starioninstruments.com.


'/>"/>
SOURCE Starion Instruments
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Healthcare Cancer Profiler Used in Study
2. Pharmacopeia Initiates Second Phase 2 Hypertension Study with PS433540 (DARA)
3. Genetic Variation Associated with Treatment Response in a Clinical Study of a New Atypical Antipsychotic Fiaptatm (iloperidone)
4. CMC, Moffitt Partner to Study Cancer
5. Pharmacopeia Completes Enrollment in Phase 2 Hypertension Study with PS433540 (DARA)
6. Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting
7. EndoGastric Solutions(TM) Announces Results of EsophyX(TM) Multi-Center GERD Study
8. Alegent Health Sees Positive Results From Recent Clinician Usability Study Collaboration With Siemens and Motion Computing
9. MacuSight(TM) Announces Positive Preliminary Results From Phase 1 Study of Sirolimus in Wet Age-Related Macular Degeneration
10. InteKrin Therapeutics Announces Initiation of Phase 2b Study in Type 2 Diabetes with INT131
11. Study Data Shows VNUS ClosureFAST(TM) Catheter More than 96% Effective
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... 2017  Axium Pharmaceuticals Inc., the creator of the drug Truveta ... beginning stages of an IPO. The United States ... average cost of a prescription epilepsy drug being $450.00-$1200.00 for a one ... AXIUM PHARMACEUTICALS, INC ... Another staggering figure is the fact that Americans spent $42 billion ...
(Date:8/14/2017)... and PETACH TIKVAH, Israel ... (NASDAQ: BCLI), a leading developer of adult stem cell ... second quarter ending June 30, 2017. ... of preparing for our pivotal Phase 3 trial to ... Lebovits , President and Chief Executive Officer of BrainStorm. ...
(Date:8/8/2017)... 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... financial results for the second quarter ended June 30, ... quarter 2017 and to date: ... for the Company,s lead project, BL-8040: ... BL-8040 as novel stem cell mobilization treatment for autologous ...
Breaking Medicine Technology:
(Date:8/19/2017)... Texas (PRWEB) , ... August 19, 2017 , ... ... with contemporary illustrations of breastfeeding mothers. These illustrations show the diversity ... available in prints in a wide range of sizes. These illustrations are also ...
(Date:8/19/2017)... ... ... “Congratulations! It's A Boy! God’s Gift: A Story of Love”: a children’s book ... A Boy! God’s Gift: A Story of Love” is the creation of published authors, ... by Christian Faith Publishing, Dale Anthony and Rachael Anthony’s new book is a perfect ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... (“Quick”), a highly specialized asset-light logistics provider of complex transport solutions for ... agreement to purchase Unitrans International Corporation, a division of Roadrunner Transportation Systems, ...
(Date:8/18/2017)... ... August 18, 2017 , ... As an industry leader, ... webinar, they will present the line of epMotion automated liquid handling system. This ... can automate everyday pipetting tasks. , Ideal for scientists and lab technicians with ...
(Date:8/18/2017)... TX (PRWEB) , ... August 18, 2017 , ... ... assistance and financial planning services to communities in east Texas, is launching a ... Brain Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) ...
Breaking Medicine News(10 mins):